Our results demonstrate a crucial role for PAR4 in cerebral hemostasis following experimental TBI in mice and suggest that particular caution is warranted in the therapeutic management of PAR4-targeted treatment of coagulopathies. The gene discussed is F2RL3; the disease is blood coagulation disease.